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The Niemann-Pick type C2 protein loads
isoglobotrihexosylceramide onto CD1d
molecules and contributes to the thymic
selection of NKT cells
Nicolas Schrantz,1 Yuval Sagiv,2 Yang Liu,3 Paul B. Savage,3
Albert Bendelac,2 and Luc Teyton1
1Department

of Immunology, The Scripps Research Institute, La Jolla, CA 92037
on Immunology, University of Chicago, Chicago, IL 60637
3Department of Chemistry, Brigham Young University, Provo, UT 84602

The Niemann-Pick type C2 (NPC2) protein is a small, soluble, lysosomal protein important
for cholesterol and sphingolipid transport in the lysosome. The immunological phenotype of
NPC2-deficient mice was limited to an impaired thymic selection of V𝛂14 natural killer
T cells (NKT cells) and a subsequent reduction of NKT cells in the periphery. The remaining
NKT cells failed to produce measurable quantities of interferon-𝛄 in vivo and in vitro after
activation with 𝛂-galactosylceramide. In addition, thymocytes and splenocytes from NPC2deficient mice were poor presenters of endogenous and exogenous lipids to CD1d-restricted
V𝛂14 hybridoma cells.
Importantly, we determined that similar to saposins, recombinant NPC2 was able to
unload lipids from and load lipids into CD1d. This transfer activity was associated with
a dimeric form of NPC2, suggesting a unique mechanism of glycosphingolipid transfer by
NPC2. Similar to saposin B, NPC2 dimers were able to load isoglobotrihexosylceramide (iGb3),
the natural selecting ligand of NKT cells in the thymus, into CD1d. These observations
strongly suggested that the phenotype observed in NPC2-deficient animals was directly
linked to the efficiency of the loading of iGb3 into CD1d molecules expressed by
thymocytes. This conclusion was supported by the rescue of endogenous and exogenous
iGb3 presentation by recombinant NPC2. Thus, the loading of endogenous and exogenous
lipids and glycolipids onto CD1d is dependent on various small, soluble lipid transfer
proteins present in the lysosome.

CORRESPONDENCE
Luc Teyton:
lteyton@scripps.edu
Abbreviations used: DHE,
dehydroergosterol; GM2a, GM2
activator; iGb3, isoglobotrihexosylceramide; LacCer, lactosylceramide; LTP, lipid transfer
protein; NKT cell, NK T cell;
NPC1, Niemann-Pick type C1;
NPC2, Niemann-Pick type C2;
NTA, nitrilotriacetic acid.

CD1 molecules are nonpolymorphic MHC
class I–like proteins that associate with β2microglobulin and present lipids and glycolipids
to the immune system. Mammalian CD1 proteins segregate into group I (CD1a, CD1b, and
CD1c) and group II (CD1d) based on sequence
homologies (1, 2). Mice express CD1d only.
Its distribution is limited to macrophages, monocytes, B cells, DCs, and cortical thymocytes
(3, 4). CD1d is the restriction element for two
groups of T cells that recognize lipids. The first
group is indistinguishable from classic T cells
and has been identified in humans for lipids
as diverse as mycobacterial mycolic acids and
endogenous sulfatide (5–7). The second group
represents a unique, small population of T cells
The online version of this article contains supplemental material.
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called NK T cells (NKT cells) that is essential
for the regulation of immune responses (8).
NKT cells represent an ideal system for the
study of lipid antigens because agonist ligands
such as α-galactosyl and α-glucuronosyl ceramides have been identified, and the main
thymic selecting ceramide, isoglobotrihexosylceramide (iGb3), is known (9, 10). NKT cells
express a unique TCR-α chain (Vα14-Jα18
in the mouse and Vα24-Jα18 in the human)
paired with a restricted set of Vβ segments (Vβ8,
Vβ7, and Vβ2 in the mouse and Vβ11 in the
human; references 11, 12).
Unlike conventional αβ T cells, NKT cells
are selected by CD4+CD8+ cortical thymocytes, not by epithelial cells (12, 13). This selection process requires the intracellular trafficking
of CD1d to late endosomal and lysosomal
841
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that NPC2 participates in the loading of endogenous lipids
into CD1d and in the selection of NKT cells. Therefore,
as suggested in this study, multiple lysosomal LTPs can operate to establish the repertoire of lipids to be presented to the
immune system.
RESULTS
NPC2-deficient mice exhibit a reduction of V𝛂14 NKT cells
Thymocytes, splenocytes, and hepatic and blood lymphocytes from 7-wk-old NPC2−/− or littermate control mice
were stained with CD1d-αGalCer tetramers. On the BALB/c
background, the proportion of tetramer-positive cells in
NPC2-deficient mice was dramatically reduced in all tissues
(Fig. 1 A). In the spleen and liver, the tetramer-positive cells
represented 18% and 20%, respectively, of the population observed in the WT littermate control (Fig. 1 A). In the thymus, tetramer and antibody staining distinguished two subsets
of NKT cells: a resident thymic population (CD1d-αGalCer
tetramerintermediate, CD44high, CD49b+) and a larger population of cells that will immigrate to the periphery (CD1dαGalCer tetramerhigh, CD44intermediate, CD49b−; Fig. S2;
references 30, 31). NPC2 deficiency was accompanied by
an almost complete disappearance of the CD1d-αGalCer
tetramerhigh CD44int population (2% of the littermate control
population) that persisted over time (Fig. 1 B), whereas the
CD1d-αGalCer tetramerint CD44high population was reduced
to 25% early on (Fig. 1 A) but accumulated intrathymically to
reach normal levels at 12 wk (Fig. 1 B). The Vα14 NKT cell
selection defect was specific for Vα14 NKT cells because the
thymus and the spleen of NPC2-deficient mice exhibited
normal numbers of CD4, CD8, and B cells (Fig. S1, available
at http://www.jem.org/cgi/content/full/jem.20061562/DC1).
Identical results were obtained from NPC2 mice bred on the
mixed B6/129 background (unpublished data).
These results indicate that there is a selective decrease in
the thymic selection, a normal emigration to the periphery,
and a small but noticeable expansion in the periphery of
Vα14 NKT cells in the absence of NPC2 protein. The progressive accumulation of the resident thymic NKT cell population was reproducible but never led to increased numbers in
the periphery in any of the older animals, clearly separating
the behavior of these two populations.
The remaining population of NKT cells in NPC2−/− animals
has limited functionality
The addition of the increasing concentration of αGalCer
and Galα1-2GalCer to whole spleen cells leads to an NKT
cell–dependent production of IFN-γ (32, 33). As expected,
NPC2−/− NKT cells failed to produce or induce the production (through NK stimulation; reference 34) of a detectable
amount of IFN-γ with either lipid (Fig. 2 A) in this assay, as
they also did in vivo after i.v. injection of 2 μg αGalCer
(Fig. 2 B). In this latter instance, a very limited NKT cell
expansion was noticeable 6 d after the injection of αGalCer
and was comparable with the WT when expressed as fold
expansion using day 0 as a reference (Fig. 2, C and D).
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compartments (14). The main endogenous self-glycolipid
that, once bound to CD1d, selects canonical Vα14 NKT
cells was recently identified as iGb3, a sphingolipid that is
produced in small quantities by iGb3 synthases and mainly by
the degradation of isoglobotetrahexosylceramide by glycosidase β–hexosaminidase b, as illustrated by the absence of
Vα14 NKT cells in hexosaminidase b–deficient mice (10, 15).
We have shown in vitro and in vivo that iGb3 could not
load CD1d spontaneously but rather required the assistance
of lipid transfer proteins (LTPs) such as saposin (10). The
number of known lysosomal LTPs is limited, and their main
members are saposins A–D, GM2 activator (GM2a), and
Niemann-Pick type C2 (NPC2; references 16–18). The overlap
of transfer activity between these different molecules is rather
large, as they all bind similar glycolipids such as gangliosides
(19, 20). However, each has its own specificity and profile, as
exemplified by the capacity of saposin B and GM2a to transfer αGalCer to CD1d and the inability or low activity of any
of the other saposins to do so (reference 21; unpublished data).
This situation suggested to us that in the lysosome, the repertoire of lipid bound to CD1 could be the result of glycolipid
loading by multiple LTPs.
NPC2 is a 22-kD soluble lysosomal glycoprotein that is
expressed ubiquitously and secreted as a mannose-6-phosphate–tagged protein (22, 23). NPC2 is the only small LTP
that has been identified consistently in the lysosomal proteome next to saposin (17, 18). NPC2 binds and transfers
cholesterol, but its precise function is still undefined (24). Its
deficiency leads to a small (5%) complementation group of
Niemann-Pick disease, which is clinically indistinguishable
from Niemann-Pick type C1 (NPC1) deficiency (25, 26).
The identical phenotype is rather surprising, as evidence has
accumulated to demonstrate that there are no physical relationships between the two molecules (17, 27, 28).
However, immunological phenotypes appear to be sufficiently subtle to attribute specific functions to both NPC1
and NPC2 and separate the two complementation groups.
We have recently reported that NPC1-deficient mice lacked
Vα14 NKT cells and that this phenotype was linked to an
abnormal trafficking of sphingolipid antigens to the lysosome,
which is secondary to a late endosomal block/accumulation
(29). In the present study, we investigated the impact of a
deficiency in NPC2 production with respect to Vα14 NKT
development and functions. As for NPC1-deficient mice, the
NPC2-deficient animal exhibited an important reduction of
Vα14 NKT cell numbers, and the presentation of endogenous and exogenous lipid antigens by NPC2-deficient thymocytes and splenocytes was substantially reduced. However,
in contrast to NPC1 deficiency, NPC2 absence did not lead
to a noticeable late endosomal block of lipid trafficking to the
lysosome. Antigen presentation deficiency was reversed by
the addition of exogenous recombinant NPC2. In vitro,
NPC2 was able to load iGb3 into CD1d molecules, and only
dimers of the molecule were able to transfer iGb3 and other
glycolipids to CD1, arguing that cholesterol and sphingolipid
transfers by NPC2 might operate differently. Our data indicate
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in each group. (B) Age-related variations of NKT cell numbers. Thymocytes
from 3-, 7-, and 12-wk-old WT and NPC2−/− mice were stained with
CD1d-αGalCer tetramer and anti-CD44 antibody. Percentages of CD1dαGalCer tethigh CD44int and CD1d-αGalCer tetint CD44high cells are indicated in the gates. The numbers of animals analyzed per group are
four, two, and five for 3 wk, 7 wk, and 12 wk, respectively. Cellularity
of the thymus of NPC2−/− animals was normal at 3 and 7 wk and
diminished by 30% at 12 wk of age (70.5 ± 27%) as compared
with littermate controls.

This result strongly argued that the IFN-γ phenotype was
linked to antigen presentation rather than to an inherent
NKT cell dysfunction. A more detailed analysis of CD1drestricted antigen presentation was undertaken in vitro.

from deficient animals were then evaluated in vitro by using
the classic DN32.D3 assay (21). This assay appreciates the
expression of CD1d–iGb3 complexes in tissues by testing
the capacity of primary cells such as thymocytes to stimulate
the production of IL-2 from Vα14-DN32.D3 T cell
hybridoma cells in the absence of exogenous antigen. Similar to the situation encountered in the absence of CD1d
expression, NPC2−/− thymocytes were unable to stimulate
DN32.D3 cells (Fig. 3 A). In contrast, the non-Vα14 NKT
hybridoma TBD7 was responding identically to NPC2−/−
and WT thymocytes, whereas the stimulation of TCB11 was
reduced by 50% in the absence of NPC2 (Fig. 3 B). These
results suggested that NPC2 deficiency specifically impaired
the presentation of iGb3 by CD1d-expressing thymocytes

Defective presentation of endogenous and exogenous
lipid antigens by thymocytes and splenocytes
from NPC2-deficient mice
The expression of CD1d molecules was normal in NPC2−/−
animals on all cellular subsets tested, especially B cells, DCs,
and thymocytes, excluding a functional knockout of CD1d
and a subsequent NKT cell deficiency (Fig. S3, available
at http://www.jem.org/cgi/content/full/jem.20061562/DC1).
The antigen-presenting capacities of CD1d-expressing cells
JEM VOL. 204, April 16, 2007
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Figure 1. NPC2-deficient mice exhibit a reduction of NKT cells.
(A) Vα14 NKT cells from the thymus, liver, spleen, and blood of 7-wk-old
WT or NPC2-deficient (NPC2−/−) mice were stained with CD1d-αGalCer
tetramers and CD44 or TCR-β. The values in the gates indicate the absolute
numbers of Vα14 NKT cells as represented by their percentages of the
lymphocyte population in each organ. For the thymus, percentages are
split in CD1d-αGalCer tethigh CD44int and CD1d-αGalCer tetint CD44high
cells. Percentages in the liver are percentages out of all lymphocytes. The
figure is representative of two independent experiments with two animals
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injected i.v. to WT (closed squares) and NPC2−/− (open squares) mice.
The expansion of Vα14 NKT cells was followed in blood at different time
points by staining peripheral blood lymphocytes with CD1d-αGalCer
tetramer and anti–TCR-β antibody and was expressed as a percentage
of lymphocytes (C) or fold increase using day 0 as a reference (D). All
experiments were performed twice with two animals per group. Error
bars represent SD.

but not (or only partially) the presentation of some other endogenous lipids.
The presentation of exogenous lipids was tested with
αGalCer and Galα1-2GalCer, two agonists of NKT cells that
are partially and completely dependent on endosomal functions, respectively (33). Stimulation of DN32.D3 by thymocytes and splenocytes from NPC2−/−-deficient mice pulsed
with αGalCer was decreased and similar to presentation by
CD1d−/− cells, whereas the processing/presentation of Galα12GalCer was abolished (Fig. 3, C and D). The presentation by
BM-derived DCs (BMDCs) of these same two lipids was only
marginally affected (Fig. 3 E). This same phenotype of lipid
presentation deficiency was found throughout the life of the
NPC2−/− animals, as we tested mice of 3, 6, 8, 9, 10, 13, and
14 wk of age.
These results demonstrated that thymocytes and splenocytes that both express similar amounts of NPC2 in the WT
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1) required NPC2 for the presentation of
exogenous lipids. This specific deficit argued that the absence
of NPC2 did not grossly affect the CD1d/lipid-loading compartments. This functionality of the late endosomal/lysosomal
compartments was confirmed by testing the presentation of
MHC class II–restricted proteins such as OVA. D011.10 T
cell hybridoma cells that recognize the OVA peptide 323–339
in the context of I-Ab/d were stimulated normally by NPC2−/−
splenocytes incubated with intact OVA (Fig. 3 F).

Trafficking of glycosphingolipids in NPC2-deficient cells
Confocal microscopic analysis of splenocytes from WT and
NPC2−/− mice showed that CD1d was normally localized
in the lysosome-associated membrane protein 1–positive late
endosome/lysosome compartment of NPC2−/− cells (Fig. 4 A),
where lipid antigens are loaded in CD1d (35). Abnormal
lipid trafficking in NPC1−/− cells has been extensively documented (22, 36, 37). Because of cholesterol accumulation
in the endosomal pathway, the transport of lactosylceramide
(LacCer) to the Golgi is heavily disturbed, and fluorescent
forms of αGalCer accumulate in the late endosome without
ever reaching the lysosome (29). Similar studies on NPC2−/−
cells are scarce and poorly documented. Fluorescent LacCer
was fed to WT and NPC2−/− fibroblasts for 30 min and
observed by confocal microscopy on live cells after a 90-min
chase (Fig. 4 B). WT and mutant cells looked very similar,
with a predominant distribution of LacCer to the Golgi
apparatus (Fig. 4 B). In addition to Golgi staining, some
NPC2−/− cells exhibited small vesicular staining reminiscent of LacCer distribution in NPC1−/− cells (29, 38), indicating some minor defects in endosomal transport, as would
be expected.
The accumulation of cholesterol and gangliosides in cells
was analyzed by flow cytometry by measuring the accumulation of Lysotracker green after a short pulse of ingestion
(39). The storage of lipids in NPC2−/− cells was more important in splenocytes and BMDCs than in thymocytes and
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Figure 2. In vivo and in vitro functional analysis of V𝛂14 NKT
cells. (A) Splenocytes from WT (closed symbols) or NPC2−/− (open symbols)
were cultured with various concentrations of αGalCer (squares) or
Galα1-2αGalCer (circles), and IFN-γ production in culture supernatants
was measured by ELISA. (B) WT (closed squares) and NPC2−/− (open
squares) mice were injected i.v. with 2 μg αGalCer, and the production
of IFN-γ in serum was measured by ELISA. (C and D) 2 μg αGalCer was
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Figure 3. Defective presentation of endogenous and exogenous
lipid antigens by thymocytes and splenocytes from NPC2-deficient
mice. (A and B) IL-2 production by DN32.D3 hybridoma T cells (A) and
non-Vα14 hybridoma TCB11 (gray) and TBD7 (black; B) cultured with
thymocytes from NPC2−/−, WT, and CD1d−/− mice. Data are representative
of three independent experiments. (C–E) Presentation of αGalCer and
Galα1-2GalCer by thymocytes (C), splenocytes (D), and BMDCs (E) from

JEM VOL. 204, April 16, 2007

WT (closed squares) and NPC2−/− (open squares) mice. Data are representative of four independent experiments using mice between the ages of
6 and 9 wk. (F) Presentation of OVA protein by splenocytes from WT
(closed squares) and NPC2−/− (open squares) mice to DO11.10 T cell hybridoma. IL-2 was measured at 24 h. Data are representative of two independent experiments. Error bars represent SD.
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analyzed by flow cytometry. Unstained (green), WT (red), and NPC2−/− (blue)
profiles are presented. (D) Primary fibroblasts from WT and NPC2−/− mice
were pulsed overnight with BODIPY–PBS-81 (green) and Lysotracker red
(red) the next day and observed by confocal microscopy. Individual green
and red channels as well as the overlay are presented. (E) Splenocytes
were pulsed overnight with BODIPY–PBS-81 (green) and Lysotracker red
(red) the next day and observed by confocal microscopy. Individual green
and red channels as well as the overlay are presented. Bars (A), 5 μm;
(B and D) 10 μm; (E) 2 μm.

fibroblasts when compared with the WT (Fig. 4 C). Because
BMDCs and splenocytes were discordant for their presentation phenotype, we can conclude that there is no correlation
between the degree of lysosomal lipid accumulation and lipid
antigen presentation. The same profile of lysosomal accumulation in NPC2−/− cells was demonstrated for cholesterol
using filipin staining (Fig. S5, available at http://www.jem
.org/cgi/content/full/jem.20061562/DC1).
The overall normal transport and localization of glycosphingolipids in NPC2−/− cells was confirmed by examining
the uptake and intracellular trafficking of a fluorescentlabeled derivative of αGalCer (BODIPY-αGalCer and PBS81) in fibroblasts and splenocytes. Cells were pulsed for 5 h
(Fig. S6, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1) or overnight with PBS-81 and the lysosomal marker Lysotracker red and observed by confocal
microscopy. PBS-81 accumulated in small peripheral transport vesicles and lysosomes, where they costained with the
lysosomal dye. This pattern was indistinguishable between

WT and NPC2-deficient cells (Fig. 4, D and E) even though
the lysosomal compartment of NPC2−/− cells was consistently larger. Similar results were observed in BMDCs (unpublished data). These results indicated that unlike NPC1-deficient
cells, NPC2-deficient cells exhibited a relatively normal uptake and trafficking of Vα14 NKT cell ligands through the
endosomal compartments and to the lysosome, where they
could be loaded into CD1d.
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In vitro transfer of lipids to CD1d molecules by NPC2
recombinant molecules
Recombinant mouse NPC2 was produced in a fly expression
system and purified by a succession of nickel–nitrilotriacetic
acid (NTA) agarose, cation, and gel filtration chromatographies (40). This protocol allowed the separation of monomers and nondisulfide-linked dimers of NPC2 (Fig. 5 A).
The dimeric form of mouse NPC2 was also observed after
expression in HeLa cells (Fig. 5 B). Like human NPC2 protein
expressed in Chinese hamster ovary cells (41), fly-expressed
NIEMANN-PICK TYPE C2 PROTEIN AND NKT CELLS | Schrantz et al.
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Figure 4. Trafficking of glycosphingolipids in WT and NPC2−/−
cells. (A) Splenocytes were analyzed by confocal fluorescence microscopy
for Lamp-1 (green) and CD1d (red). Individual green and red channels
as well as the overlay are presented. (B) BM-derived primary fibroblasts
from WT and NPC2−/− mice were pulsed with BODIPY-LacCer (green) and
observed by confocal microscopy. (C) Evaluation of the late endosomal/
lysosomal compartment size in WT and NPC2−/− cells. Thymocytes, splenocytes, BMDCs, and BM-derived fibroblasts from WT or NPC2−/− mice
were stained with Lysotracker, and the fluorescence of the cells was
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increasing concentrations of GM3 in the absence (white bars) or presence
of 50 μM NPC2 dimers (gray bars) or 50 μM NPC2 monomers (black
bars). The percentage of GM3 loading is indicated. (E) 2.5 μM CD1d–GT1b
complexes were incubated with increasing concentrations of NPC2 monomers (white bars) and dimers (black bars). Unloading is indicated as a
percentage of GT1b removal. (F) NPC2 dimers load iGb3 into CD1d. 2.5 μM
CD1d–GT1b complexes were incubated with increasing concentrations of
NPC2 dimers in the absence or presence of 20 μM iGb3 C18 (iGb3). Lipid
unloading and loading were visualized by native IEF. Relative positions of
CD1d, CD1d–GT1b, and CD1d–iGb3 are indicated by arrows. Error bars
represent SD.

mouse NPC2 protein was able to bind the fluorescent cholesterol analogue dehydroergosterol (DHE; Fig. 5 C). Interestingly, NPC2 dimers and monomers were able to bind
DHE similarly (Fig. 5 C). Using a cell-free assay, we tested
the ability of NPC2 dimers and monomers to transfer
GM3 into CD1d (10, 21, 42). In the absence of NPC2,
GM3 was poorly loaded onto CD1d. In the presence of dimers but not monomers of NPC2, the loading of GM3
into CD1d was substantially increased (Fig. 5 D). The loading of GM3 into CD1d by dimers of NPC2 was not modified by the presence of cholesterol (unpublished data).
Using CD1d molecules loaded with GT1b, we analyzed the
ability of NPC2 to unload GT1b from CD1d–GT1b complexes. Again, only NPC2 dimers were able to unload GT1b
from CD1d (Fig. 5 E).

A similar situation was encountered when we tested the
ability of NPC2 to load iGb3 into CD1d (Fig. 5 F). So far, in
vitro, only saposin B had been shown to transfer iGb3 efficiently to CD1d, but recombinant NPC2 was efficient in
carrying this function. This result suggests that both LTPs
might act in the lysosome to load natural ligands into CD1d
and select NKT cells.

JEM VOL. 204, April 16, 2007

Recombinant NPC2 protein enhances the presentation
of ligands to V𝛂14 NKT cells
NPC2 accesses the lysosome after secretion through cellular uptake by the mannose-6-phosphate receptor (23). To
evaluate the capacity of recombinant NPC2 to increase the
uptake and loading of exogenous lipids into CD1d, WT and
NPC2−/− splenocytes were pulsed with iGb3 in the presence
847
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Figure 5. Oligomerization of NPC2 and in vitro loading and
unloading of lipids into and from CD1d by recombinant NPC2. (A) Gel
filtration profile and Coomassie blue gel of purified recombinant NPC2
protein. Fractions containing monomers and enriched in NPC2 dimers are
indicated (arrows in the profile; monomers [m] and dimers [d] in the gel).
(B) Expression of NPC2 in HeLa cells. Lysates from transfected HeLa cells
were boiled in the presence of SDS or left untreated and analyzed by
Western blotting using anti-Flag antibody. (C) Interaction of fly-expressed
NPC2 protein with DHE. Fluorescent spectra of samples containing 10 μM
NPC2 monomer (NPC2m) and 10 μM NPC2 dimer (NPC2d) with or without 1 μM DHE. Spectra of samples containing buffer or 1 μM DHE only
are also shown. (D) 2.5 μM CD1d–GT1b complexes were incubated with
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DISCUSSION
The selection of Vα14 NKT cells in the thymus is dependent
on the expression of iGb3–CD1d complexes by cortical thymocytes. Presentation of the endogenous iGb3 by CD1d
molecules requires the presence of iGb3 in the lysosomes and
its assisted loading into CD1d by LTPs. We previously showed
that the impaired production of iGb3 or the lack of saposins
resulted in the severe deficiency or lack of Vα14 NKT cells
(10, 21). In an attempt to find other lysosomal LTPs involved
in the loading of lipid antigens into CD1d, we investigated
whether NPC2 could play a role in Vα14 NKT cell selection
and lipid antigen presentation.
Our study establishes that a deficiency in NPC2 profoundly affects the numbers of Vα14 NKT cells in the thymus and peripheral tissues. It is important to notice that this
phenotype was observed in mice and cells that have some residual NPC2 activity (27) and that a complete knockout of
expression would likely reinforce the traits that we observed.
The thymic phenotype reveals two pieces of information:
(a) NPC2 is required for the normal selection of Vα14 NKT
cells, and (b) the resident thymic population is similarly affected, suggesting similar selecting ligands, but has the capacity
to accumulate over time, indicating that it behaves differently
from peripheral NKT cells. NPC2 is not involved in the egress
of NKT cells from the thymus as they are found in the periphery. However, the small number of exported immature
NKT cells does not lead to a normal peripheral compartment

Figure 6. Exogenous NPC2 protein enhances the presentation of
lipids by splenocytes and thymocytes from WT and NPC2−/− mice.
(A and B) Splenocytes from WT (A) or NPC2−/− (B) mice were pulsed in the
absence (white symbols) or presence of 10 (gray symbols) or 20 μg/ml
(black symbols) NPC2 and increasing concentrations of iGb3 C18 (iGb3) for
4 h and were incubated with DN32.D3. IL-2 production was measured at

24 h. Data are representative of two independent experiments. (C) Thymocytes from WT and NPC2−/− mice were incubated for 24 h in the absence
or presence of 10 or 20 μg/ml NPC2 or GM2a and with DN32.D3 T cells.
Data are representative of two independent experiments. Error bars
represent SD.
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or absence of recombinant NPC2 and were used to stimulate DN32.D3 hybridoma cells. WT splenocytes presented
iGb3 to DN32.D3 hybridoma with a typical dose/response
curve (Fig. 6 A), whereas NPC2−/− splenocytes presented
only the highest concentration of iGb3 (Fig. 6 B). The addition of recombinant NPC2 slightly increased the presentation of iGb3 by WT splenocytes and established normal levels
of stimulation by NPC2-deficient cells (Fig. 6, A and B). This
effect required CD1d, as cells from CD1d−/− mice could not
stimulate DN32.D3 cells in the presence of recombinant NPC2
(unpublished data). The addition of recombinant GM2a,
which was produced in the same expression system, did not
rescue the phenotype, confirming the specificity of the effect
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1).
Similarly, in the absence of exogenous lipid, the addition
of recombinant NPC2 to NPC2−/− thymocytes restored the
presentation of endogenous lipids, as illustrated by the stimulation of DN32.D3 cells (Fig. 6 C). The same addition of recombinant NPC2 to WT thymocytes slightly increased their
stimulatory activity (Fig. 6 C). The addition of recombinant
GM2a, which was produced and purified similarly, did not
rescue the phenotype or alter presentation (Fig. 6 C). Rescue
of the antigen presentation phenotype of NPC2−/− cells by
the addition of recombinant NPC2 directly demonstrates
the role of NPC2 in the presentation of endogenous and exogenous lipids.
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NPC1−/− and NPC2−/− cells with respect to lipid endocytosis and transport reinforce the idea that the two molecules are
present in different compartments: late endosomes for NPC1
and lysosomes for NPC2 (46, 47). This dichotomy could explain why NPC2 did not grossly perturb endocytosis and
transport to the lysosome. However, the absence of NPC2 in
the lysosome could affect the egress of lipids from this compartment; this issue will need further inquiry.
Our initial assessment of the degree of lipid storage in
various cell types by using lysosomal dyes showed that NPC2
deficiency affected mostly splenocytes and BMDCs, whereas
thymocytes were only marginally perturbed. We can conclude
from this observation that lipid accumulation and presentation phenotypes are not correlated. This dissociation is one
additional argument against a nonspecific effect of lipid storage as the cause for the observed phenotype resulting from the
absence of NPC2.
Collectively, these observations suggest a direct role of
NPC2 in the transport and loading of glycolipids into CD1d.
The poor presentation of exogenous lipids and the almost
complete absence of endogenous ligand presentation in
NPC2−/− mice support this role, as does the in vitro loading
of iGb3 into CD1d. However, the ability of recombinant
NPC2 to complement the deficient phenotype is the most
compelling argument supporting this hypothesis. In addition, the observation that only dimers of NPC2 are capable of
transferring glycosphingolipids, whereas both dimers and
monomers can bind cholesterol, suggests that the binding
of cholesterol and the transfer of glycosphingolipids by NPC2
are mechanistically different. The engineering of mutants of
NPC2, which cannot form dimers, will help clarify this
point further.
In summary, this study establishes that NPC2 is critical
for the loading of iGb3 and exogenous lipids into CD1d.
This observation suggests a model in which multiple LTPs
present in the CD1d-containing compartments, such as saposin and NPC2, select the repertoire of CD1d-presented lipids
and glycosphingolipids (17, 18). The polymorphism of NPC2
will have to be studied in the context of NKT cells to determine whether pathological conditions are associated with
variants of NPC2 that might affect immune functions.
MATERIALS AND METHODS
Mice. NPC2- and CD1d-deficient mice have been described previously
(27, 48). NPC2 mice have been backcrossed six times in the BALB/c background. NPC2-deficient mice and littermate controls were obtained by intercrossing heterozygous mice. The genotype was determined by PCR as
described previously (27). WT (NPC2+/+) and heterozygote (NPC2+/−)
littermate mice were indistinguishable and are referred as WT. In all experiments, WT age-matched littermate mice were used as a control. NPC2deficient mice are hypomorph, expressing 4–5% of the normal levels of NPC2.
Genetrap NPC2-deficient mice in a BL6 background were also analyzed
(B6;129P2-Npc2Gt(pGT1TMpfs)1Ucd/Mmc; BayGenomics) and were indistinguishable from the hypomorph with respect to their immunological phenotype.
All mice were bred at The Scripps Research Institute Animal Facility
according to Institutional Animal Care and Use Committee guidelines.
Cell culture. Fresh thymocytes, splenocytes, liver lymphocytes, and cultured
BMDCs were obtained as described previously (32, 35). Primary fibroblasts
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through expansion, as the deficit remains severe throughout
the life of these animals.
The delay observed in the expansion of peripheral NKT
cells in NPC2−/− animals suggests that in these mice, mainly
DCs present αGalCer to Vα14 NKT cells, as it is known that
the injection of αGalCer-pulsed DCs induces a delayed expansion of Vα14 NKT cells and cytokine production as
compared with the injection of αGalCer alone (43). In
addition, the normal degree of expansion of Vα14 NKT
cells in NPC2−/− mice suggests that NPC2 deficiency does
not affect the function of Vα14 NKT cells but only antigen presentation.
The defect of the presentation of exogenous glycosphingolipid such as αGalCer and Galα1-2αGalCer by NPC2deficient splenocytes and thymocytes, whereas the presentation
of these same lipids by BMDCs was only slightly affected, indicates that the LTP requirements for exogenous lipid uptake
and presentation are different between various cell types. It
also strongly suggests a model in which multiple LTPs shape
the repertoire of lipid presented by CD1d molecules. This
hypothesis is also supported by the profile of stimulation of
non-Vα14 NKT cells by NPC2−/− cells. Although TCB11
stimulation was normal, TBD7 stimulation was partially affected.We have not encountered this discrepant phenotype in
prosaposin-deficient animals and GM2a−/− mice in which
both stimulations were normal (references 10, 21; unpublished data). The almost normal presentation of lipids by DCs
derived from NPC2−/− mice also suggests that in vitro matured DCs do not faithfully represent some of the DC subsets
present (for example, in the spleen).This situation will compel
us to examine the presentation capacity of NPC2−/− DCs
directly isolated and purified from spleen and lymph nodes to
understand these discrepancies.
With respect to lipid trafficking, cholesterol and gangliosides, including GM2 and GM3, have been shown to accumulate in mice deficient in NPC1 (27, 38). In addition, the
transport of BODIPY-LacCer to the Golgi and of fluorescent
αGalCer to the lysosome in NPC1−/− cells has been shown
to be heavily perturbed with the presence of a late endosomal
block (29, 37, 38). A similar study in NPC2−/− cells has been
very limited besides establishing that some cell types were accumulating cholesterol in the absence of NPC2 (44). Moreover, important differences between NPC1−/− and NPC2−/−
cells have been documented for the transport of GM2 ganglioside to the lysosome (45). Whereas NPC1−/− cells could not
deliver GM2 to the lysosome, NPC2−/− cells could internalize GM2 into endocytic vesicles and deliver it to the lysosome
(45). Our evaluation of the transport of LacCer and PBS-81
in NPC2−/− fibroblasts and splenocytes is very much in agreement with this observation. The transport of these two glycolipids through the endocytic pathway appeared close to normal
in most cells. A morphometric quantification of these results
will allow us to appreciate the precise numbers of vesicles in
which lysosomal markers and PBS-81 colocalize in WT and
mutant cells and also to compare the impact of NPC2 deficiency in different cell types. These major differences between
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were recovered from 7-d-old bone marrow culture by trypsination of the
dish after washing out nonadherent cells. Cells were cultured in a 1:1 mixture of Click’s medium and RPMI supplemented with 10% heat-inactivated
FCS, glutamine, antibiotics, and 5 × 10−5 M β2- mercaptoethanol. Primary
skin fibroblasts were obtained by digesting mice skin with 1 mg/ml collagenase
D (Roche) at 37°C in DMEM supplemented with 10% heat-inactivated
FCS for 5 h. After digestion, cells were washed several times in PBS and
cultured in DMEM supplemented with 10% heat-inactivated FCS, glutamine, antibiotics, and 5 × 10−5 M β2-mercaptoethanol.

T cell hybridoma in vitro stimulation. APCs used in T cell hybridoma
in vitro stimulation were obtained from NPC2−/− and WT littermate mice
between 3 and 9 wk of age. To measure autoreactivity, DN32.D3, TCB11,
and TBD7 NKT hybridomas (5 × 104 cells/well) were incubated in the
presence of 5 × 105 fresh thymocytes for 24 h, and IL-2 released in cultured
supernatants was measured using an IL-2–dependent NK cell line (21). 0.5
μCi [3H]thymidine was added to each well after a 24-h incubation. Results
are expressed as mean counts per minute of triplicates.
To study the presentation of exogenous lipids, fresh thymocytes or splenocytes (5 × 104 cells/well) or 2 × 104 BMDCs were pulsed with or without NPC2 and various concentrations of lipids for 4 h. After incubation,
APCs were washed three times and incubated with DN32.D3 hybridoma
cells (5 × 104 cells/well) for 24 h. IL-2 released in cultured supernatants was
measured as described in the previous paragraph.
To study the effect of recombinant NPC2 on autoreactivity, fresh thymocytes (5 × 104 cells/well) were incubated with or without NPC2 and
DN32.D3 hybridoma cells (5 × 104 cells/well) for 24 h. IL-2 released in
cultured supernatants was measured as described above.
To study MHC class II–mediated antigen presentation, after irradiation,
splenocytes were incubated for 24 h with various concentrations of OVA
protein and the T cell hybridoma specific for the peptide 323–339 of OVA
in the context of I-Ad/I-Ab and DO11.10 (gift of S. Webb, The Scripps
Research Institute, La Jolla, CA). IL-2 release in cultured supernatants was
measured as described above. For whole spleen activation assay, fresh splenocytes (5 × 105 cells/well) were cultured with various concentrations of
lipids for 48 h. IFN-γ released in the culture supernatant was measured by
ELISA (BD Biosciences).
Mice immunization. WT or NPC2-deficient mice were immunized by
i.v. injection in the tail vein with 2 μg αGalCer diluted in PBS or with
vehicle only. Blood was collected at different time points after immunization
and used for NKT cell analysis or IFN-γ production quantification.
Synthesis of V𝛂14 NKT cell ligands. PBS-81 was synthesized as reported previously for related compounds with the addition of the fluorophore
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Confocal microscopy. To study Vα14 NKT cell ligand trafficking, cells
were grown on poly-l-lysine–coated coverslips (BD Biosciences) and incubated for 5 h or overnight with 10 μM PBS-81 at 37°C. To stain lysosomes,
primary fibroblasts were incubated for 30 min with 1 μM Lysotracker red
(Invitrogen), and splenocytes were incubated for 15 min with 0.1 μM Lysotracker red. For LacCer trafficking, cells were incubated for 30 min at 37°C
with 5 μm BSA-complexed BODIPY FL C5-LacCer (Invitrogen), washed
three times with media, and incubated for 90 min at 37°C with media. Cells
were washed three times with 2% FBS in PBS, and coverslips were mounted
on slides with 2% FBS in PBS and a 1:50 dilution of oxyFluor (Oxyrase,
Inc.). Live cells were examined immediately at room temperature by confocal microscopy using a laser-scanning confocal microscope (MRC1024;
Bio-Rad Laboratories) with a 63× plan-Apo 1.4 NA oil objective lens (Carl
Zeiss MicroImaging, Inc.) and a krypton/argon mixed gas laser, which excites at 488, 568, and 647 nm and records simultaneously in three separate channels.
To stain free cholesterol, cells were fixed with 4% paraformaldehyde for
15 min at 25°C, washed with PBS, and stained with 50 μg/ml filipin for
30 min. Cells were washed and analyzed with a laser-scanning confocal microscope (Radiance 2100 Rainbow; Bio-Rad Laboratories) with a 100× oil
objective lens (Carl Zeiss MicroImaging, Inc.). For CD1d and Lamp-1 colocalization studies, after fixation with 3.7% formaldehyde for 15 min, cells
were quenched for 10 min with 50 mM NH4Cl in PBS and blocked with
4% FBS, 0.5% BSA, and 0.1% saponin in PBS for 30 min. Cells were incubated with a rat monoclonal anti-CD1d antibody (16G9; reference 51) in 4%
FBS, 0.5% BSA, and 0.1% saponin in PBS for 60 min, washed with PBS,
and incubated with a Texas red-X–conjugated goat anti–rat IgG antibody
(Invitrogen). Cells were washed three times with PBS and incubated with
a FITC-conjugated rat monoclonal anti–Lamp-1 antibody (BD Biosciences)
in 4% FBS, 0.5% BSA, and 0.1% saponin in PBS for 60 min. Stained cells
were mounted on slides with Mowiol (EMD Bioscience) and analyzed by
confocal microscopy.
NPC2 and GM2a production/purification. Recombinant mouse NPC2
was expressed in a fly expression system (40). In brief, mouse NPC2 cDNA
was subcloned into the expression vector pRMHa-3, and an N-terminal
histidine tag was incorporated. Cells were cultured in roller bottles, and
NPC2 protein was purified from the media using nickel-NTA agarose beads
(QIAGEN) after tangential flow concentration. The protein was purified
using a MonoS column (GE Healthcare) to further remove contaminating
proteins and applied to a Superdex 200 column (GE Healthcare) to separate
the dimer from the monomer form of NPC2. Fractions containing monomers only or enriched with the dimer forms of NPC2 were pooled and used
for in vitro loading or activation assays. Mouse GM2a was produced using a
similar approach and was purified by combination nickel-NTA agarose-ion
exchange chromatography.
In vitro CD1d-loading assay. Recombinant mouse CD1d was expressed in a fly expression system (40). Purified complexes of CD1d–GT1b
were used to study the exchange of lipid into CD1d (21, 42). 2 μM
mCD1d–GT1b was incubated with various concentrations of NPC2 dimers
and in the presence or absence of GM3 or iGb3. Lipid unloading and loading
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Flow cytometry. CD1d-αGalCer tetramers were generated and used as
described previously (40). FITC-conjugated anti-CD4, –TCR-β, and - CD44
and allophycocyanin-conjugated anti-CD8 antibodies were purchased from
BD Biosciences. Allophycocyanin-conjugated anti-B220 and -CD49b
and PE–cyanin 7–conjugated anti-CD44 antibodies were obtained from
eBioscience. Cells positive for propidium iodide and/or unloaded CD1d
tetramer were excluded from analysis. Data were acquired using a flow cytometer (LSR2; Becton Dickinson) and analyzed using FACSDiva software
(Becton Dickinson) and Flowjo software (Tree Star, Inc.). 106 events were
typically recorded.
To evaluate lysosome size, thymocytes, splenocytes, BMDCs, and fibroblasts from 6-wk-old WT or NPC2−/− mice were stained with 200 nM
Lysotracker green (Invitrogen) for 10 min. After washing, cells were analyzed by flow cytometry. Data were acquired using a FACSCalibur (Becton
Dickinson) and Flowjo software. To evaluate cellular cholesterol content,
cells from WT or NPC2−/− mice were fixed for 15 min with 4% paraformaldehyde, washed in Hanks’ balanced salt solution, and stained for 2 h at
25°C with 100 μg/ml filipin (Sigma-Aldrich) in Hanks’ balanced salt solution.
Fluorescence emission was measured by flow cytometry (49).

(BODIPY FL; Invitrogen) at position six of the galactose via an amine (Fig.
S8, available at http://www.jem.org/cgi/content/full/jem.20061562/
DC1; reference 50). To incorporate the fluorophore, the N-hydroxylsuccinimicyl ester of 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene3-propionic acid (Invitrogen) was used. The structures of PBS-81 were
confirmed by 1H and 13C nuclear magnetic resonance spectroscopy and
mass spectrometry.
iGb3 C8 and iGb3 C18 were synthesized as reported previously (Fig.
S8; references 10, 29), and C8 and C18 acyl chains, respectively, were used
in place of a C26 chain. The structures of iGb3 C8 and IGb3 C18 were
confirmed by 1H and 13C nuclear magnetic resonance spectroscopy and
mass spectrometry.
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into CD1d were visualized using IEF gel and were quantified using
UN-SCAN-IT gel digitizing software (Silk Scientific; references 10, 21).
The percentages were calculated as follows: percentage of GM3 loading
into CD1d = (CD1d–GM3/(CD1d–GM3 + CD1d–GT)) × 100. Percentage of GT1b unloading = (CD1d unloaded/(CD1d unloaded +
CD1d–GT1b)) × 100.
RNA extraction and semiquantitative PCR. Fresh thymocytes and
splenocytes from NPC2−/− and WT mice were obtained as previously described (32, 33). Cells were washed with cold PBS, and total RNA was isolated using TRIzol reagent (Invitrogen). cDNA were generated using 1 μg of
total RNA and the Superscript III First-Strand synthesis system (Invitrogen).
NPC2 and actin (used as an internal control) mRNA were amplified by
PCR, and the products were visualized using agarose gel.

Expression of NPC2 in HeLa cells. The mouse NPC2 cDNA was subcloned into the expression vector pcDNA3 with an N-terminal Flag tag.
Cells were transiently transfected using LipofectAMINE (Invitrogen). 24 h
after transfection, cells were washed with PBS and lysed by incubation for
30 min on ice with lysis buffer (50 mM Hepes, 100 mM NaCl, 10% glycerol,
and 0.5% NP-40). Lysates were left untreated or were boiled for 5 min in the
presence of 1% SDS and resolved using 10–20% Tris-HCl precasted gels.
Proteins were detected by Western blotting using a monoclonal anti-Flag
antibody (Sigma-Aldrich).
Cholesterol-binding assay. For binding measurements, NPC2 and DHE
(Sigma-Aldrich) were diluted in PBS and incubated for 30 min at 25°C in
the dark. 200-μl samples in quartz microcells were excited at 338 nm with a
0.5-nm bandpass slit. Emission spectra were obtained from 345 to 470 nm
with a 4-nm bandpass slit. Fluorescence spectra were recorded by using a
luminescence spectrometer (LS55; PerkinElmer).
Online supplemental material. Fig. S1 shows CD4+ and CD8+ T
cells in the thymus and spleen and B cells in the spleen. Fig. S2 shows the
thymic NKT cell phenotype in WT and NPC2−/− mice. Fig. S3 shows
the expression of CD1d on thymocytes, splenocytes, and BMDCs from
WT, NPC2−/−, and CD1d−/− mice. Fig. S4 shows the expression of NPC2
in thymocytes and splenocytes. Fig. S5 shows cholesterol storage in WT
and NPC2−/− cells. Fig. S6 shows the trafficking of a fluorescent-labeled
derivative of αGalCer in WT and NPC2−/− primary skin fibroblasts. Fig. S7
shows that exogenous NPC2 protein enhances the presentation of αGalCer
by splenocytes from WT and NPC2−/− mice. Fig. S8 shows a schematic
representation of the structures of iGb3 C8, iGb3 C18, and PBS-81. Online
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1.
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